We are live on
!
Find out more
AEPBI
AH Equity Partners Bio II Portfolio holdings
AUM
$144M
1-Year Est. Return
54.61%
This Fund
S&P 500
This Quarter
Est. Return
-8.75%
1 Year Est. Return
-54.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$142M
AUM Growth
-$31.2M
(-18%)
Cap. Flow
$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 98% |
Similar funds
JAMH
SFI
MPU
HGM
EVC
SP
SC
SCM
AH Equity Partners Bio II's Q2 2022 Portfolio in Review
As of Q2 2022, AH Equity Partners Bio II held 4 positions worth $142M, down 18% from $174M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2022: portfolio turnover was 0%. AH Equity Partners Bio II opened no new positions and made no exits, leaving the 4-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 95% a quarter earlier.
- AH Equity Partners Bio II's ten largest holdings make up 100% of its $142M portfolio in Q2 2022.
- AH Equity Partners Bio II opened 0 new positions and closed 0 in Q2 2022.
- AH Equity Partners Bio II's portfolio value fell 18% quarter-over-quarter to $142M.
Based on AH Equity Partners Bio II's 13F filing for Q2 2022, filed 15 Aug 2022.